Riverhead Capital Management’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
Riverhead Capital Management's RMD Position: Q3 2019 in Review
Riverhead Capital Management reduced its ResMed (RMD) stake by 13% in Q3 2019, selling an estimated $52.4K and leaving 2,700 shares worth $365K. The position accounts for 0.01% of the portfolio, ranked #859.
Riverhead Capital Management first reported a position in RMD in Q3 2015 and has held it in 17 quarters since. The position peaked at $1.55M in Q1 2016. 528 funds tracked by Wall St. Rank hold RMD as of Q3 2019.
- Riverhead Capital Management held 2,700 shares of ResMed worth $365K as of Q3 2019.
- Riverhead Capital Management sold 400 ResMed shares in Q3 2019, an estimated $52.4K.
- ResMed made up 0.01% of Riverhead Capital Management's portfolio in Q3 2019, its #859 holding.
- Riverhead Capital Management first reported a position in ResMed in Q3 2015 and has held it in 17 quarters since.
- Riverhead Capital Management's ResMed position peaked at $1.55M in Q1 2016.
- 528 funds tracked by Wall St. Rank held ResMed as of Q3 2019.
Based on Riverhead Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.